NCT04687878View on ClinicalTrials.gov

The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

June 20, 2022

Study Completion Date

September 20, 2023

Conditions
Parkinson Disease
Interventions
DRUG

Insulin

20 IU twice a day, intranasally, every day for 12 weeks

DRUG

Normal saline

twice a day, intranasally, every day for 12 weeks

Trial Locations (1)

Unknown

Shahid Beheshti University of Medical Sciences, Shohada-e-Tajrish Hospital, Tehran

All Listed Sponsors
lead

dr.dargahi

OTHER

NCT04687878 - The Effect of Intranasal Insulin on Motor and Non-motor Symptoms in Parkinson's Disease Patients | Biotech Hunter | Biotech Hunter